Exxe : Financial Disclosures 1Q'23

QUARTERLY REPORT

FOR THE PERIOD ENDING

JUNE 30, 2022

EXXE GROUP, INC.

1345 AVENUE OF THE AMERICAS, 2ND FLOOR

NEW YORK, NY 10105

Tel: [phone]

Email:[e-mail]

URL:www.exxegroup.com

Ticker symbol: AXXA

1

EXXE GROUP, INC.

QUARTERLY REPORT

FOR THE PERIOD ENDING

June 30, 2022

(Unaudited)

Index

Condensed Consolidated Unaudited Balance Sheet	3
as at June 30, 2022, and March 31, 2022
Condensed Consolidated Unaudited Statement of Operations	5
for the Three Months Ending June 30, 2022, and June 30, 2021
Condensed Unaudited Statement of Changes in Equity	6
for the Period Ending June 30, 2022, and March 31, 2022
Condensed Consolidated Unaudited Statement of Cash Flows	7
for the Period Ending June 30, 2022, and June 30, 2021
Notes to the Condensed Consolidated Unaudited Financial Statements	8
For the Period Ending June 30, 2022
Management Discussion And Analysis	34

2

EXXE GROUP, INC.

Condensed Consolidated Unaudited Balance Sheet

as at June 30, 2022, and March 31, 2022

				As at June 30,		As at March 31,
	Notes		2022	2022
ASSETS
Current assets
Cash and cash equivalents	2	395,846	258,877
Accounts receivable	2	6,468,585	5,100,659
Inventory		11,942,782	12,357,957
Other current assets		4,495,579	5,175,506
TOTAL CURRENT ASSETS		23,302,792	22,892,999
Fixed Assets
Land and buildings	6	76,064,012	72,298,242
Less: Accumulated Depreciation		(372,426)	(331,776)
TOTAL FIXED ASSETS		75,691,586	71,966,466
Other Assets
Long-term receivables	5	12,445,272	12,387,547
Goodwill	7	92,747,311	92,747,311
Other long-term assets		354,997	354,997
Software, Contracts	7	53,075,345	53,075,345
TOTAL ASSETS			257,617,303	253,424,665

3

LIABILITIES & STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities

Accounts payable, trade		5,244,574	6,933,217
Accrued expenses and other current liabilities		9,450,216	7,302,165
Loans payable - related parties	8	5,614,565	5,300,218
Convertible debt - in default	8	262,308	262,308
Short-term or current loans and notes payable	8	3,769,029	3,840,120
TOTAL CURRENT LIABILITIES		24,340,691	23,638,028
Long-term debt		56,525,384	56,525,384
TOTAL LIABILITIES		80,866,075	80,163,412
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock:
Preferred stock series A: par value $0.0001, 4
authorized and 1 issued and outstanding at March 31,
2022 and March 31, 2021	9	0	0
Preferred stock series B: par value $2.50, 20,000,000
authorized 1,768,754 and 568,754 issued and
outstanding at March 31, 2021 and March 31, 2022
respectively	9	4,421,885	4,421,885
Preferred stock series C: par value $2.00, 20,000,000
authorized and 16,111,813 and 13,211,813 issued
and outstanding as at March 31, 2021 and March 31,
2022 respectively	9	32,223,626	32,223,626
Common stock: par value $0.00001, 680,000,000 and
500,000,000 authorized; 640,095,768 and
526,932,673 issued and outstanding as at March 31,
2021 and March 31, 2022 respectively	9	6,621	6,401
Additional paid-in capital		23,232,548	22,995,168
Minority interest		111,663,024	111,663,024
Accumulated comprehensive income (loss)		(285,544)	(285,544)
Accumulated surplus (deficit)		5,489,068	2,236,693
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)		176,751,228	173,261,253
TOTAL LIABILITIES AND STOCKHOLDERS'		257,617,303	253,424,665
EQUITY (DEFICIT)

The accompanying notes are an integral part of the financial statements

4

EXXE GROUP, INC.

Condensed Consolidated Unaudited Statement of Operations for the Three Months Ending June 30, 2022, and June 30, 2021

	Three Months Ending June 30,
	2022	2021
Revenues	11,734,232	11,022,713
Cost of goods sold	2,048,879	6,667,209
Gross profit	9,685,353	4,355,504
Operating expenses	5,748,765	2,188,118
Selling, general & administration costs	450,609	53,016
Depreciation and amortization	85,284	54,056
Total operating expenses	6,284,658	2,295,190
Income (loss) from operations	3,400,695	2,060,314
Other income (expenses)	358,382	35,362
Financing costs	(294,369)	0
Other income (expenses)	(212,333)	(263,801)
Income (loss) before income taxes	3,252,375	1,831,875
Provision for income taxes	0	0
Net income (loss)	3,252,375	1,831,875
Net income (loss) per share	0.0050		0.0034
Weighted average shares outstanding	655,568,295	544,066,373
Comprehensive income
Net income (loss)	3,252,375	1,831,875
Exchange rate movements
Comprehensive income (loss)	3,252,375	1,831,875

The accompanying notes are an integral part of the financial statements

5